Similar results were also reported by Routy et al., where the oral administration of Akkermansia muciniphila restored the efficacy of anti-PD1 therapy though an Il-12 dependent mechanism allowing the recruitment of CD4+ T cells to the tumor microenvironment [30]. Here, PDCD1 is linked to neoplasm.